CLICK HERE to view the associated slides.
Healthcare Analysts Tom Tobin and Andrew Freedman were live in the studio earlier today. Watch the replay below.
CLICK HERE to download the slides associated with this presentation.
Topics will included:
- JOLTS release this morning
- Update on MEDNAX (MD)
- Key takeaways from their proprietary maternity tracker
- And what's next for Valeant (VRX)
Hedgeye CEO Keith McCullough joined Fox Business host Liz Claman this afternoon to discuss how to invest following a dovish March Fed meeting. In the panel was U.S. Global Investors CEO Frank Holmes and Jefferies Chief Financial Economist Ward McCarthy.
daily macro intelligence
Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.
In this excerpt from The Macro Show this morning, Hedgeye CEO Keith McCullough responds to a subscriber’s question on investing in a world riddled with global central bank interventionism.
Takeaway: Whatever the Fed decides to do or say today, this week's industrial production and retail sales data reaffirms our dour US economic outlook.
Investors are waiting with bated breath for the FOMC statement and Janet Yellen's testimony. Unfortunately, no matter what the Fed does or Yellen says today, the Fed is not omnipotent and cannot arrest economic gravity.
Case in point... today's industrial production number which yet again affirms our view that sections of the U.S. economy are already in recession.
Or how about Retail Sales? That too was disappointing.
(...That's just this week's data.)
We've got a 73-page slide deck laying out our view that U.S. economic growth is stalling. Here's a taste:
CLICK TO WATCH
But why pay attention to all of this when Janet Yellen is simply going to tell us it's "all good" at 2:30PM ET?
Risk Managed Long Term Investing for Pros
Hedgeye CEO Keith McCullough handpicks the “best of the best” long and short ideas delivered to him by our team of over 30 research analysts across myriad sectors.